Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.74 EUR | 0.00% | -0.36% | +21.78% |
May. 10 | Laboratorio Reig Jofre, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 13 | Transcript : Laboratorio Reig Jofre, S.A., 2023 Earnings Call, Mar 13, 2024 |
Sales 2022 | 274M 297M | Sales 2023 | 318M 344M | Capitalization | 177M 192M |
---|---|---|---|---|---|
Net income 2022 | 8M 8.66M | Net income 2023 | 9M 9.74M | EV / Sales 2022 | 0.82 x |
Net Debt 2022 | 54.76M 59.26M | Net Debt 2023 | 47.92M 51.85M | EV / Sales 2023 | 0.71 x |
P/E ratio 2022 |
21.9
x | P/E ratio 2023 |
18.8
x | Employees | 1,331 |
Yield 2022 |
1.83% | Yield 2023 |
-
| Free-Float | 21.21% |
Latest transcript on Laboratorio Reig Jofre, S.A.
1 week | -0.36% | ||
Current month | +10.04% | ||
1 month | +8.73% | ||
3 months | +19.13% | ||
6 months | +15.61% | ||
Current year | +21.78% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 05-12-31 | |
Carmen Esclapés
CTO | Chief Tech/Sci/R&D Officer | - | 02-12-31 |
Chief Operating Officer | 52 | 02-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 05-12-31 | |
Director/Board Member | - | 14-12-30 | |
Director/Board Member | - | 14-12-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 2.74 | 0.00% | 24 064 |
24-05-21 | 2.74 | +2.24% | 39,569 |
24-05-20 | 2.68 | -1.83% | 15,764 |
24-05-17 | 2.73 | -0.73% | 10,068 |
24-05-16 | 2.75 | 0.00% | 25,005 |
Delayed Quote BME, May 22, 2024 at 06:58 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+21.78% | 234M | |
+37.78% | 723B | |
+30.64% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.06% | 244B | |
-5.03% | 208B | |
+9.84% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- RJF Stock